Innovative Grant Opportunity for Groundbreaking Brain Tumor Research
The Brain Tumor Funders' Collaborative (BTFC) has unveiled a significant opportunity aimed at enhancing the understanding and treatment of primary brain tumors through innovative research. This initiative primarily focuses on liquid biopsy, a cutting-edge approach that utilizes biological fluids to examine tumor characteristics, potentially revolutionizing patient diagnosis and monitoring.
Details of the Grant Program
With plans to distribute two research grants worth $500,000 each, the BTFC invites proposals for multi-institutional and multi-disciplinary studies. This initiative aims to promote pivotal research that can dramatically change current practices in brain tumor care and provide a viable, less invasive diagnostic tool for physicians. The eligibility for this grant is extended to teams comprising two or more faculty-level researchers collaborating from different institutions.
Understanding Liquid Biopsy
Liquid biopsy involves analyzing blood, cerebral spinal fluid, or other biofluids to find nucleic acid fragments, proteins, or tumor cells. The method's ability to capture tumor-related biological insights makes it a promising avenue for early detection and treatment monitoring in brain tumor patients, which include pediatric, adolescent and young adult, and adult populations.
Support from Leading Organizations
Notably, the American Brain Tumor Association (ABTA), as a founding member of the BTFC, has expressed its support for this endeavor. Ralph DeVitto, President and CEO of ABTA, emphasized the potential of liquid biopsy in identifying brain tumors and tracking their progression, particularly as it pertains to over 1 million affected individuals in the U.S. and 55,000 in Canada.
Collaborative Efforts
The BTFC's mission is classically amplified through its alliance with four prominent advocacy organizations: the ABTA, Brain Tumour Foundation of Canada, National Brain Tumor Society, and Pediatric Brain Tumor Foundation. In addition to its partners, the initiative receives backing from numerous foundations, creating a robust network of support dedicated to enhancing brain tumor research.
Purpose and Focus Areas of Study
The BTFC actively seeks research proposals that target a variety of age groups and tumor types. Projects that aim to use liquid biopsy for various purposes, such as screening, diagnosing, detecting minimal residual disease, and monitoring responses to treatments are especially encouraged. These focal points highlight the grant's commitment to facilitating transformative research in brain cancer treatment and management.
Community Commitment to Curing Cancer
As stated by Geoff Still, Chief Financial and Operating Officer at the Pediatric Brain Tumor Foundation, this collaboration signifies a unified commitment to combat cancer in children, emphasizing that each organization values the potential of joint efforts in driving successful outcomes.
Funding timeline and application process
The deadline for submitting letters of intent for funding consideration is January 16, 2025, highlighting the urgency for researchers passionate about making a meaningful impact in neuro-oncology. Interested participants can find the application guidelines on the BTFC website.
About the Brain Tumor Funders' Collaborative
The BTFC serves as a strategic partnership that pools resources among philanthropic and advocacy organizations dedicated to improving the lives of patients with brain tumors. With a history of awarding over $11 million since its inception in 2005, the BTFC is firmly focused on channeling critical resources into effective research initiatives to build a brighter future for those affected by brain tumors.
Frequently Asked Questions
What is the BTFC?
The Brain Tumor Funders' Collaborative is a partnership among prominent philanthropic organizations aimed at advancing brain tumor research and improving patient care.
How much funding is available through the BTFC grant?
Each research grant awarded by the BTFC is valued at $500,000 for a two-year research project.
Who can apply for the grant?
Teams of two or more faculty-level researchers from different institutions are eligible to apply for the grant.
What areas can research projects focus on?
Research can focus on using liquid biopsy for screening, diagnosis, treatment monitoring, and understanding tumor behavior, among other critical areas.
How can interested researchers access application materials?
Researchers can find the application details and proposals on the BTFC official website, with the letter of intent due by January 16, 2025.
